Alexandria Co. For Pharmaceuticals & Chemical Industries

CASE:AXPH Stock Report

Market Cap: ج.م1.6b

Alexandria For Pharmaceuticals & Chemical Industries Balance Sheet Health

Financial Health criteria checks 5/6

Alexandria For Pharmaceuticals & Chemical Industries has a total shareholder equity of EGP795.0M and total debt of EGP813.1K, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are EGP1.2B and EGP446.0M respectively. Alexandria For Pharmaceuticals & Chemical Industries's EBIT is EGP267.5M making its interest coverage ratio -19.8. It has cash and short-term investments of EGP150.0M.

Key information

0.1%

Debt to equity ratio

ج.م813.07k

Debt

Interest coverage ratio-19.8x
Cashج.م150.04m
Equityج.م794.98m
Total liabilitiesج.م446.04m
Total assetsج.م1.24b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: AXPH's short term assets (EGP858.9M) exceed its short term liabilities (EGP436.5M).

Long Term Liabilities: AXPH's short term assets (EGP858.9M) exceed its long term liabilities (EGP9.6M).


Debt to Equity History and Analysis

Debt Level: AXPH has more cash than its total debt.

Reducing Debt: AXPH's debt to equity ratio has increased from 0% to 0.1% over the past 5 years.

Debt Coverage: AXPH's debt is well covered by operating cash flow (23322%).

Interest Coverage: AXPH earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies